Results 11 to 20 of about 17,773 (204)

Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease

open access: yesBlood Advances, 2022
Kaposi sarcoma–associated herpesvirus (KSHV)/human herpesvirus 8–associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder that mainly occurs in immunocompromised hosts.
Chbihi, Marwa   +47 more
core   +3 more sources

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome

open access: yesFrontiers in Microbiology, 2012
Soon after the discovery of Kaposi sarcoma (KS)-associated herpesvirus (KSHV), it was appreciated that this virus was associated with most cases of multicentric Castleman disease (MCD) arising in patients infected with human immunodeficiency virus.
Mark N. Polizzotto   +3 more
doaj   +2 more sources

Understanding KSHV vIRF-2-cell interactions [PDF]

open access: yes, 2011
Kaposi’s sarcoma-associated herpes virus (KSHV) encodes genes with immunomodulatory potential, one of which is vIRF-2 that shares homology to cellular interferon regulatory factors.
Mutocheluh, Mohamed
core   +7 more sources

HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma-Like Tumors Into Immunocompetent Mice. [PDF]

open access: yesJ Med Virol
ABSTRACT The Kaposi Sarcoma herpesvirus (KSHV) causes Kaposi sarcoma (KS), primary effusion lymphoma, a lymphoproliferative disease (KSHV‐multicentric Castleman's disease), and a cytokine inflammatory syndrome (KICS). These diseases occur more frequently, though not exclusively, among people living with HIV or other types of immune dysregulation. While
Naipauer J   +10 more
europepmc   +2 more sources

kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi’s sarcoma cells

open access: yesCancer Management and Research, 2019
Jing Zhang,1,2 Xiong-Ming Pu,3 Yan Xiong41Postgraduate College of Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Department of Pathology, Affiliated Traditional Chinese Medicine Hospital, Xinjiang Medical University ...
Zhang J, Pu XM, Xiong Y
doaj   +1 more source

The Significance of cGAS-STING Signaling in Response to Oncogenic Viruses. [PDF]

open access: yesCell Biochem Funct
ABSTRACT The cyclic GMP‐AMP synthase (cGAS)‐stimulator of interferon genes (STING) signaling pathway, as a key DNA sensor, plays a significant role in the regulation of innate immune responses. This pathway can be activated by sensing abnormal DNA, and is of great significance for resisting the invasion of pathogenic microorganisms and maintaining ...
Guo L, Li L, Wang F, Liu W, Zhang Y.
europepmc   +2 more sources

KSHV: forgotten but not gone [PDF]

open access: yesBlood, 2011
Thirty years ago, Kaposi sarcoma (KS) arose as a prominent manifestation of the AIDS epidemic. Seventeen years ago we discovered the virus that causes KS,1 Kaposi sarcoma–associated herpesvirus (KSHV), and within a year KSHV had been also shown to be the likely cause of AIDS-associated primary effusion lymphoma (PEL)2 and most cases of multicentric ...
Moore, Patrick S., Chang, Yuan
openaire   +2 more sources

Redefining KSHV Latency [PDF]

open access: yesCell Host & Microbe, 2013
In this issue of Cell Host & Microbe, Chang and Ganem (2013) report that Kaposi's sarcoma-associated herpesvirus infection of lymphatic endothelial cells (LECs), but not blood endothelial cells (BECs), activates mTORC1 signaling and sensitizes LECs to rapamycin-induced killing.
Yogev, Ohad, Boshoff, Chris
openaire   +2 more sources

KSHV: Immune Modulation and Immunotherapy [PDF]

open access: yesFrontiers in Immunology, 2020
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is associated with KS, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). To ensure its own survival and propagation, KSHV employs an extensive network of viral proteins to subvert the host immune system, resulting in lifelong latent infection.
Grant Broussard   +4 more
openaire   +3 more sources

Pan‐gammaherpesvirus control via a broadly neutralising gB antibody [PDF]

open access: yesClin Transl Med
Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
Jiang Z, Li P, Xie C, Sun C.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy